Bharat Immunologicals & Biologicals share news, announcements and annual reports
BSE: 524663Pharmaceuticals & BiotechnologySmall Cap
Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1994
Last close ₹8.87down ₹0.08 (0.89%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹8.95.
30 Oct: open ₹8.95, high ₹9.09, low ₹8.60
52-week range of traded prices to 30 Oct 2026
₹7.11Low, 6 Oct 2026₹22.61High, 23 Dec 2025
- Under BSE's graded surveillance, stage 0, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹38 Cr3,103rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 13,480
Bharat Immunologicals & Biologicals shareholding disclosures
8 filed, newest first.
Jul 2014
Jun 2014
May 2014
Apr 2014
Jan 2014
Oct 2010
7 Oct · Disclosure
IFCI Ltd has submitted the disclosure under Regulation 7(1A) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE